+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Preimplantation Genetic Testing Market by Testing Type, Test Type, Technology Type, Offering, End User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 184 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4968718
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Preimplantation Genetic Testing Market is undergoing significant transformation as healthcare providers and stakeholders seek more precise, data-driven solutions to enhance fertility outcomes and genetic insights.

Market Snapshot: Preimplantation Genetic Testing Market

The global Preimplantation Genetic Testing Market grew from USD 780.19 million in 2024 to USD 873.74 million in 2025. It is expected to continue expanding at a CAGR of 12.23%, reaching USD 1.55 billion by 2030. This robust trajectory reflects rising demand for precision diagnostics, along with growing acceptance of advanced reproductive technologies across developed and emerging markets. Market momentum is shaped by ongoing innovation, evolving regulatory landscapes, and the continued prioritization of patient safety and successful fertility outcomes.

Scope & Segmentation

This report delivers a comprehensive assessment of the Preimplantation Genetic Testing Market, offering deep insight across technologies, offerings, end users, and geographies. The segmentation structure supports targeted analysis to inform commercial and investment decisions:

  • Testing Type: PGT-A (Aneuploidy), PGT-M (Monogenic Disorders), PGT-SR (Structural Rearrangements)
  • Test Type: Preimplantation Genetic Diagnosis, Preimplantation Genetic Screening
  • Technology Type: Comparative Genomic Hybridization, Fluorescent In-Situ Hybridization, Next-Generation Sequencing, PCR-Based Testing, Single-Nucleotide Polymorphism
  • Offering: Instruments, Reagents & Consumables, Software
  • End User: Diagnostic Laboratories, Fertility Clinics, Hospitals, Research Institutes
  • Region: Americas (including United States: California, Texas, New York, Florida, Illinois, Pennsylvania, Ohio; Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (United Kingdom, Germany, France, Russia, Italy, Spain, United Arab Emirates, Saudi Arabia, South Africa, Denmark, Netherlands, Qatar, Finland, Sweden, Nigeria, Egypt, Turkey, Israel, Norway, Poland, Switzerland), Asia-Pacific (China, India, Japan, Australia, South Korea, Indonesia, Thailand, Philippines, Malaysia, Singapore, Vietnam, Taiwan)
  • Major Companies: Abbott Laboratories, Agilent Technologies, Inc., Bio-Techne Corporation, Bioarray S.L., EUROPE IVF International s.r.o., F. Hoffmann-La Roche AG, Genea Limited, GENETiKS, Illumina, Inc., Invicta Genetics, Invitae Corporation, Juno Genetics, US Inc., Laboratory Corporation of America Holdings, MedGenome Labs Ltd., Merck KGaA, Natera, Inc., NextGen Genetics Holdings, LLC, Ovation Fertility, PacGenomics, PerkinElmer, Inc., Progyny, Inc., Qiagen N.V., Quest Diagnostics Incorporated, Reproductive Genetic Innovations, LLC, SEQUENCE46, LLC, Sysmex Corporation, Takara Bio Inc., The Cooper Companies Inc., Thermo Fisher Scientific Inc., Vitrolife Sweden AB, Yikon Genomics (Shanghai) Co., Ltd.

Key Takeaways for Decision-Makers

  • Technological integration—such as high-throughput sequencing and advanced analytics—continues to expand diagnostic precision and reduce result turnaround times.
  • Strong collaboration among laboratory scientists, fertility specialists, and genetic counselors helps raise standards and accelerates the adoption of innovative embryo testing protocols.
  • Adoption curves differ widely by region; policy harmonization, infrastructure investment, and local regulations are shaping market accessibility and operational feasibility.
  • Strategic alliances and acquisitions are empowering companies to broaden portfolios, optimize regional reach, and address specific clinical needs.
  • End users span centralized laboratories, dedicated fertility clinics, hospitals, and research institutions, each requiring specialized solutions and customer-centric support.
  • The growing focus on integrating genetic counseling and sustainable workflow automation is creating lasting operational advantages for leading stakeholders.

Tariff Impact on Preimplantation Genetic Testing Supply Chains

Recent United States trade tariffs introduced in 2025 present supply chain challenges, especially for laboratories and distributors reliant on imported test components. Tariffs have prompted vendors to seek alternative supply arrangements, implement buffer stock practices, and invest in localized manufacturing. These adjustments are supporting continued operational continuity but are likely to shape pricing strategies and supply resilience for the foreseeable future.

Methodology & Data Sources

The research methodology incorporates structured interviews with clinical, laboratory, and policy experts, supplemented by analysis of peer-reviewed literature, regulatory documents, and device approval records. Quantitative results are validated through cross-referencing of performance metrics, while thematic trends emerge from systematic coding of expert commentary. The process ensures consistency, transparency, and minimization of bias.

Why This Report Matters

  • Gain a strategic overview of key growth drivers, innovation landscapes, and evolving regulatory trends in the Preimplantation Genetic Testing Market.
  • Identify opportunities and risk factors relevant to product development, operational investments, and partnership strategies across major global regions.
  • Leverage actionable segmentation and regional insights to refine go-to-market approaches for new and existing offerings.

Conclusion

The Preimplantation Genetic Testing Market is moving quickly toward more advanced, patient-centric approaches, with data-driven decision-making at its core. Effective strategy relies on technological expertise, regulatory awareness, and agile partnerships to achieve long-term success in this complex global arena.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Adoption of noninvasive embryo testing techniques through spent culture media analysis for improved genetic screening outcomes
5.2. Integration of artificial intelligence and machine learning algorithms for automated embryo evaluation in preimplantation testing
5.3. Expansion of preimplantation genetic testing for monogenic and polygenic disorders to support personalized reproductive planning
5.4. Emergence of portable next-generation sequencing platforms enabling rapid and cost-effective preimplantation genetic analysis
5.5. Evolving ethical guidelines and regulatory frameworks shaping global standards for preimplantation genetic testing practice
5.6. Growing demand for telehealth-enabled genetic consultations to enhance access to preimplantation testing services in remote regions
5.7. Strategic partnerships between fertility clinics and biotechnology firms to accelerate innovation in preimplantation genetic testing
5.8. Increasing affordability of whole genome sequencing driving broader adoption of comprehensive preimplantation screening solutions
5.9. Rising interest in direct-to-consumer preimplantation genetic screening offerings through digital fertility platforms
5.10. Focus on health equity initiatives to expand preimplantation genetic testing availability in underserved populations
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Preimplantation Genetic Testing Market, by Testing Type
8.1. Introduction
8.2. PGT-A (Aneuploidy)
8.3. PGT-M (Monogenic Disorders)
8.4. PGT-SR (Structural Rearrangements)
9. Preimplantation Genetic Testing Market, by Test Type
9.1. Introduction
9.2. Preimplantation Genetic Diagnosis
9.3. Preimplantation Genetic Screening
10. Preimplantation Genetic Testing Market, by Technology Type
10.1. Introduction
10.2. Comparative Genomic Hybridization
10.3. Fluorescent In-Situ Hybridization
10.4. Next-Generation Sequencing
10.5. PCR-Based Testing
10.6. Single-Nucleotide Polymorphism
11. Preimplantation Genetic Testing Market, by Offering
11.1. Introduction
11.2. Instruments
11.3. Reagents & Consumables
11.4. Software
12. Preimplantation Genetic Testing Market, by End User
12.1. Introduction
12.2. Diagnostic Laboratories
12.3. Fertility Clinics
12.4. Hospitals
12.5. Research Institutes
13. Americas Preimplantation Genetic Testing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Preimplantation Genetic Testing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Preimplantation Genetic Testing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Abbott Laboratories
16.3.2. Agilent Technologies, Inc.
16.3.3. Bio-Techne Corporation
16.3.4. Bioarray S.L.
16.3.5. EUROPE IVF International s.r.o.
16.3.6. F. Hoffmann-La Roche AG
16.3.7. Genea Limited
16.3.8. GENETiKS
16.3.9. Illumina, Inc.
16.3.10. Invicta Genetics
16.3.11. Invitae Corporation
16.3.12. Juno Genetics, US Inc.
16.3.13. Laboratory Corporation of America Holdings
16.3.14. MedGenome Labs Ltd.
16.3.15. Merck KGaA
16.3.16. Natera, Inc.
16.3.17. NextGen Genetics Holdings, LLC
16.3.18. Ovation Fertility
16.3.19. PacGenomics
16.3.20. PerkinElmer, Inc.
16.3.21. Progyny, Inc.
16.3.22. Qiagen N.V.
16.3.23. Quest Diagnostics Incorporated
16.3.24. Reproductive Genetic Innovations, LLC
16.3.25. SEQUENCE46, LLC
16.3.26. Sysmex Corporation
16.3.27. Takara Bio Inc.
16.3.28. The Cooper Companies Inc.
16.3.29. Thermo Fisher Scientific Inc.
16.3.30. Vitrolife Sweden AB
16.3.31. Yikon Genomics (Shanghai) Co., Ltd.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PREIMPLANTATION GENETIC TESTING MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2024 VS 2030 (%)
FIGURE 6. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. PREIMPLANTATION GENETIC TESTING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. PREIMPLANTATION GENETIC TESTING MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 25. PREIMPLANTATION GENETIC TESTING MARKET: RESEARCHAI
FIGURE 26. PREIMPLANTATION GENETIC TESTING MARKET: RESEARCHSTATISTICS
FIGURE 27. PREIMPLANTATION GENETIC TESTING MARKET: RESEARCHCONTACTS
FIGURE 28. PREIMPLANTATION GENETIC TESTING MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. PREIMPLANTATION GENETIC TESTING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-A (ANEUPLOIDY), BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-A (ANEUPLOIDY), BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-M (MONOGENIC DISORDERS), BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-M (MONOGENIC DISORDERS), BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-SR (STRUCTURAL REARRANGEMENTS), BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PGT-SR (STRUCTURAL REARRANGEMENTS), BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC DIAGNOSIS, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC SCREENING, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PREIMPLANTATION GENETIC SCREENING, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COMPARATIVE GENOMIC HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENT IN-SITU HYBRIDIZATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FLUORESCENT IN-SITU HYBRIDIZATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PCR-BASED TESTING, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY PCR-BASED TESTING, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SINGLE-NUCLEOTIDE POLYMORPHISM, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY INSTRUMENTS, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY REAGENTS & CONSUMABLES, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY SOFTWARE, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY FERTILITY CLINICS, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 54. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 55. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 56. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 57. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 58. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 59. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 60. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 61. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 62. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 63. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 64. AMERICAS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 65. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 66. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 67. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 68. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 69. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 70. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 71. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 72. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 73. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 74. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 75. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 76. UNITED STATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 77. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 78. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 79. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 80. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 81. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 82. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 83. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 84. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 85. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 86. CANADA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 87. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 88. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 89. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 90. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 91. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 92. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 93. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 94. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 95. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 96. MEXICO PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 97. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 98. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 99. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 100. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 101. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 102. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 103. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 104. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 105. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 106. BRAZIL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 107. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 108. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 109. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 110. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 111. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 112. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 113. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 114. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 115. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. ARGENTINA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 118. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 119. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 120. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 121. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 122. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 123. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 124. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 129. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 130. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 131. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 132. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 133. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 134. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 135. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 136. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 137. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. UNITED KINGDOM PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 140. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 141. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 142. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 143. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 144. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 145. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 146. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 147. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 148. GERMANY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 149. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 150. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 151. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 152. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 153. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 154. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 155. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 156. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 157. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. FRANCE PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 160. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 161. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 162. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 163. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 164. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 165. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 166. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 167. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 168. RUSSIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 169. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 170. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 171. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 172. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 173. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 174. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 175. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 176. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 177. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. ITALY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 180. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 181. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 182. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 183. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 184. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 185. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 186. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 187. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 188. SPAIN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 189. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 190. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 191. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 192. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 193. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 194. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 195. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 196. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 197. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. UNITED ARAB EMIRATES PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 200. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 201. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 202. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 203. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 204. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 205. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 206. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 207. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 208. SAUDI ARABIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 209. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 210. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 211. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 212. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 213. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 214. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 215. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 216. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 217. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. SOUTH AFRICA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 220. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 221. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 222. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 223. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 224. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 225. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 226. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 227. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 228. DENMARK PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 229. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 230. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 231. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 232. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 233. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 234. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 235. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 236. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 237. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 238. NETHERLANDS PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 239. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 240. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 241. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 242. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 243. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 244. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 245. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 246. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 247. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 248. QATAR PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 249. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 250. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 251. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 252. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 253. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 254. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 255. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 256. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 257. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 258. FINLAND PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 259. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 260. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 261. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 262. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 263. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 264. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 265. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 266. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 267. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 268. SWEDEN PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 269. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 270. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 271. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 272. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 273. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 274. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 275. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 276. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 277. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 278. NIGERIA PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 279. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 280. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 281. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 282. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 283. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 284. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 285. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 286. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 287. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 288. EGYPT PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 289. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 290. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 291. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 292. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 293. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 294. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 295. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 296. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 297. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 298. TURKEY PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 299. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2018-2024 (USD MILLION)
TABLE 300. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TESTING TYPE, 2025-2030 (USD MILLION)
TABLE 301. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2018-2024 (USD MILLION)
TABLE 302. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TEST TYPE, 2025-2030 (USD MILLION)
TABLE 303. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2024 (USD MILLION)
TABLE 304. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY TECHNOLOGY TYPE, 2025-2030 (USD MILLION)
TABLE 305. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2018-2024 (USD MILLION)
TABLE 306. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY OFFERING, 2025-2030 (USD MILLION)
TABLE 307. ISRAEL PREIMPLANTATION GENETIC TESTING MARKET SIZE, BY END USER, 2018

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • Agilent Technologies, Inc.
  • Bio-Techne Corporation
  • Bioarray S.L.
  • EUROPE IVF International s.r.o.
  • F. Hoffmann-La Roche AG
  • Genea Limited
  • GENETiKS
  • Illumina, Inc.
  • Invicta Genetics
  • Invitae Corporation
  • Juno Genetics, US Inc.
  • Laboratory Corporation of America Holdings
  • MedGenome Labs Ltd.
  • Merck KGaA
  • Natera, Inc.
  • NextGen Genetics Holdings, LLC
  • Ovation Fertility
  • PacGenomics
  • PerkinElmer, Inc.
  • Progyny, Inc.
  • Qiagen N.V.
  • Quest Diagnostics Incorporated
  • Reproductive Genetic Innovations, LLC
  • SEQUENCE46, LLC
  • Sysmex Corporation
  • Takara Bio Inc.
  • The Cooper Companies Inc.
  • Thermo Fisher Scientific Inc.
  • Vitrolife Sweden AB
  • Yikon Genomics (Shanghai) Co., Ltd.

Table Information